Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-27

Clinical Trial Update: Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases [Phase 2]

View source ↗

Summary

This document provides a Phase 2 clinical trial update that accelerated checkpoint therapy for adult patients with brain metastases has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Checkpoint Therapy

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Brain Metastases, Adult | Phase 2 | Status: TERMINATED